Statement Of Comprehensive Income [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166143

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)
15,380,000 EUR
11,906,000 EUR
Other comprehensive income [abstract]
Other comprehensive income
- EUR
- EUR
Comprehensive income
15,380,000 EUR
15,380,000 EUR
10,770,000 EUR
10,770,000 EUR
11,906,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.